These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 19321618)
1. Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain. Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherieff S; Wang B; Saksena N; Purcell DF; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR J Virol; 2009 Jun; 83(11):5430-41. PubMed ID: 19321618 [TBL] [Abstract][Full Text] [Related]
2. Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages. Cashin K; Roche M; Sterjovski J; Ellett A; Gray LR; Cunningham AL; Ramsland PA; Churchill MJ; Gorry PR J Virol; 2011 Oct; 85(20):10699-709. PubMed ID: 21835796 [TBL] [Abstract][Full Text] [Related]
3. Bioinformatic prediction programs underestimate the frequency of CXCR4 usage by R5X4 HIV type 1 in brain and other tissues. Mefford ME; Gorry PR; Kunstman K; Wolinsky SM; Gabuzda D AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1215-20. PubMed ID: 18788913 [TBL] [Abstract][Full Text] [Related]
4. Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote. Gorry PR; Dunfee RL; Mefford ME; Kunstman K; Morgan T; Moore JP; Mascola JR; Agopian K; Holm GH; Mehle A; Taylor J; Farzan M; Wang H; Ellery P; Willey SJ; Clapham PR; Wolinsky SM; Crowe SM; Gabuzda D Virology; 2007 May; 362(1):163-78. PubMed ID: 17239419 [TBL] [Abstract][Full Text] [Related]
5. Replication-competent variants of human immunodeficiency virus type 2 lacking the V3 loop exhibit resistance to chemokine receptor antagonists. Lin G; Bertolotti-Ciarlet A; Haggarty B; Romano J; Nolan KM; Leslie GJ; Jordan AP; Huang CC; Kwong PD; Doms RW; Hoxie JA J Virol; 2007 Sep; 81(18):9956-66. PubMed ID: 17609282 [TBL] [Abstract][Full Text] [Related]
6. Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. Gorry PR; Bristol G; Zack JA; Ritola K; Swanstrom R; Birch CJ; Bell JE; Bannert N; Crawford K; Wang H; Schols D; De Clercq E; Kunstman K; Wolinsky SM; Gabuzda D J Virol; 2001 Nov; 75(21):10073-89. PubMed ID: 11581376 [TBL] [Abstract][Full Text] [Related]
7. Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist. Del Prete GQ; Leslie GJ; Haggarty B; Jordan AP; Romano J; Hoxie JA J Virol; 2010 Sep; 84(17):8777-89. PubMed ID: 20573813 [TBL] [Abstract][Full Text] [Related]
8. Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism. Yi Y; Isaacs SN; Williams DA; Frank I; Schols D; De Clercq E; Kolson DL; Collman RG J Virol; 1999 Sep; 73(9):7117-25. PubMed ID: 10438797 [TBL] [Abstract][Full Text] [Related]
9. The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization. Polzer S; Dittmar MT; Schmitz H; Schreiber M Virology; 2002 Dec; 304(1):70-80. PubMed ID: 12490404 [TBL] [Abstract][Full Text] [Related]
10. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism. Kato K; Sato H; Takebe Y J Virol; 1999 Jul; 73(7):5520-6. PubMed ID: 10364300 [TBL] [Abstract][Full Text] [Related]
11. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4. Cho MW; Lee MK; Carney MC; Berson JF; Doms RW; Martin MA J Virol; 1998 Mar; 72(3):2509-15. PubMed ID: 9499115 [TBL] [Abstract][Full Text] [Related]
12. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage. Verrier F; Borman AM; Brand D; Girard M AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469 [TBL] [Abstract][Full Text] [Related]
13. Genetic and functional analysis of R5X4 human immunodeficiency virus type 1 envelope glycoproteins derived from two individuals homozygous for the CCR5delta32 allele. Gray L; Churchill MJ; Keane N; Sterjovski J; Ellett AM; Purcell DF; Poumbourios P; Kol C; Wang B; Saksena NK; Wesselingh SL; Price P; French M; Gabuzda D; Gorry PR J Virol; 2006 Apr; 80(7):3684-91. PubMed ID: 16537640 [TBL] [Abstract][Full Text] [Related]
14. Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies. Singh A; Collman RG J Virol; 2000 Nov; 74(21):10229-35. PubMed ID: 11024154 [TBL] [Abstract][Full Text] [Related]
15. Identification and structural characterization of novel genetic elements in the HIV-1 V3 loop regulating coreceptor usage. Svicher V; Alteri C; Artese A; Zhang JM; Costa G; Mercurio F; D'Arrigo R; Alcaro S; Palù G; Clementi M; Zazzi M; Andreoni M; Antinori A; Lazzarin A; Ceccherini-Silberstein F; Perno CF; Antivir Ther; 2011; 16(7):1035-45. PubMed ID: 22024519 [TBL] [Abstract][Full Text] [Related]
16. Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection. Cashin K; Jakobsen MR; Sterjovski J; Roche M; Ellett A; Flynn JK; Borm K; Gouillou M; Churchill MJ; Gorry PR Retrovirology; 2013 Sep; 10():98. PubMed ID: 24041034 [TBL] [Abstract][Full Text] [Related]
17. Peptide ligands selected with CD4-induced epitopes on native dualtropic HIV-1 envelope proteins mimic extracellular coreceptor domains and bind to HIV-1 gp120 independently of coreceptor usage. Dervillez X; Klaukien V; Dürr R; Koch J; Kreutz A; Haarmann T; Stoll M; Lee D; Carlomagno T; Schnierle B; Möbius K; Königs C; Griesinger C; Dietrich U J Virol; 2010 Oct; 84(19):10131-8. PubMed ID: 20660187 [TBL] [Abstract][Full Text] [Related]
18. Characterization of a dual-tropic human immunodeficiency virus (HIV-1) strain derived from the prototypical X4 isolate HXBc2. Xiang SH; Pacheco B; Bowder D; Yuan W; Sodroski J Virology; 2013 Mar; 438(1):5-13. PubMed ID: 23369572 [TBL] [Abstract][Full Text] [Related]
19. Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. Thomas ER; Dunfee RL; Stanton J; Bogdan D; Taylor J; Kunstman K; Bell JE; Wolinsky SM; Gabuzda D Virology; 2007 Mar; 360(1):105-19. PubMed ID: 17084877 [TBL] [Abstract][Full Text] [Related]
20. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains. Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]